25 XP   0   0   10

RaySearch Laboratories AB (publ)
Buy, Hold or Sell?

Let's analyse RaySearch Laboratories AB (publ) together

PenkeI guess you are interested in RaySearch Laboratories AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of RaySearch Laboratories AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about RaySearch Laboratories AB (publ)

I send you an email if I find something interesting about RaySearch Laboratories AB (publ).

Quick analysis of RaySearch Laboratories AB (publ) (30 sec.)










What can you expect buying and holding a share of RaySearch Laboratories AB (publ)? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr21.48
Expected worth in 1 year
kr23.80
How sure are you?
72.5%

+ What do you gain per year?

Total Gains per Share
kr2.31
Return On Investment
1.9%

For what price can you sell your share?

Current Price per Share
kr118.80
Expected price per share
kr98.00 - kr123.80
How sure are you?
50%

1. Valuation of RaySearch Laboratories AB (publ) (5 min.)




Live pricePrice per Share (EOD)

kr118.80

Intrinsic Value Per Share

kr58.45 - kr438.08

Total Value Per Share

kr79.93 - kr459.57

2. Growth of RaySearch Laboratories AB (publ) (5 min.)




Is RaySearch Laboratories AB (publ) growing?

Current yearPrevious yearGrowGrow %
How rich?$67.6m$59.8m$4.7m7.3%

How much money is RaySearch Laboratories AB (publ) making?

Current yearPrevious yearGrowGrow %
Making money$1.8m$546.3k$1.3m70.9%
Net Profit Margin7.8%1.8%--

How much money comes from the company's main activities?

3. Financial Health of RaySearch Laboratories AB (publ) (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

What can you expect buying and holding a share of RaySearch Laboratories AB (publ)? (5 min.)

Welcome investor! RaySearch Laboratories AB (publ)'s management wants to use your money to grow the business. In return you get a share of RaySearch Laboratories AB (publ).

What can you expect buying and holding a share of RaySearch Laboratories AB (publ)?

First you should know what it really means to hold a share of RaySearch Laboratories AB (publ). And how you can make/lose money.

Speculation

The Price per Share of RaySearch Laboratories AB (publ) is kr118.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of RaySearch Laboratories AB (publ).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in RaySearch Laboratories AB (publ), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr21.48. Based on the TTM, the Book Value Change Per Share is kr0.58 per quarter. Based on the YOY, the Book Value Change Per Share is kr2.78 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of RaySearch Laboratories AB (publ).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.080.1%0.050.0%0.020.0%0.010.0%0.040.0%
Usd Book Value Change Per Share0.070.1%0.050.0%0.260.2%0.010.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.070.1%0.050.0%0.260.2%0.010.0%0.040.0%
Usd Price Per Share8.30-7.20-5.09-7.58-9.47-
Price to Earnings Ratio24.53-36.20-20.26-0.69-8,455.20-
Price-to-Total Gains Ratio112.69-140.02-67.03-8.25--57.82-
Price to Book Ratio4.20-3.82-2.92-4.29-7.78-
Price-to-Total Gains Ratio112.69-140.02-67.03-8.25--57.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.91772
Number of shares91
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.01
Usd Total Gains Per Share0.050.01
Gains per Quarter (91 shares)4.840.96
Gains per Year (91 shares)19.353.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1019904-6
20392808-2
3058470122
4077660156
50978501910
6011610402314
7013512302718
8015514203122
9017416103526
10019418003930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%12.08.00.060.0%30.010.00.075.0%45.015.00.075.0%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%12.08.00.060.0%29.011.00.072.5%41.016.03.068.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.060.00.0%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%12.08.00.060.0%29.011.00.072.5%41.016.03.068.3%

Fundamentals of RaySearch Laboratories AB (publ)

About RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment in the Asia-Pacific, the Middle East, the Americas, Europe, and Africa. It develops and markets RayStation, a treatment planning system; RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information. In addition, it offers µ-RayStation, a software platform for planning and evaluation in small animal irradiation research; RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Fundamental data was last updated by Penke on 2024-04-03 06:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of RaySearch Laboratories AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit RaySearch Laboratories AB (publ) earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • A Net Profit Margin of 10.5% means that kr0.11 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RaySearch Laboratories AB (publ):

  • The MRQ is 10.5%. The company is making a huge profit. +2
  • The TTM is 7.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ10.5%TTM7.8%+2.7%
TTM7.8%YOY1.8%+6.0%
TTM7.8%5Y0.7%+7.1%
5Y0.7%10Y9.3%-8.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ10.5%-21.3%+31.8%
TTM7.8%-20.1%+27.9%
YOY1.8%-29.8%+31.6%
5Y0.7%-34.6%+35.3%
10Y9.3%-42.2%+51.5%
1.1.2. Return on Assets

Shows how efficient RaySearch Laboratories AB (publ) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • 1.6% Return on Assets means that RaySearch Laboratories AB (publ) generated kr0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RaySearch Laboratories AB (publ):

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.1%+0.5%
TTM1.1%YOY0.3%+0.7%
TTM1.1%5Y0.3%+0.8%
5Y0.3%10Y2.1%-1.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6%-6.5%+8.1%
TTM1.1%-6.0%+7.1%
YOY0.3%-5.4%+5.7%
5Y0.3%-5.4%+5.7%
10Y2.1%-8.2%+10.3%
1.1.3. Return on Equity

Shows how efficient RaySearch Laboratories AB (publ) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • 4.3% Return on Equity means RaySearch Laboratories AB (publ) generated kr0.04 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RaySearch Laboratories AB (publ):

  • The MRQ is 4.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.3%TTM2.9%+1.4%
TTM2.9%YOY0.9%+2.0%
TTM2.9%5Y0.7%+2.2%
5Y0.7%10Y3.3%-2.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%-6.8%+11.1%
TTM2.9%-6.8%+9.7%
YOY0.9%-7.4%+8.3%
5Y0.7%-9.1%+9.8%
10Y3.3%-9.6%+12.9%

1.2. Operating Efficiency of RaySearch Laboratories AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient RaySearch Laboratories AB (publ) is operating .

  • Measures how much profit RaySearch Laboratories AB (publ) makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • An Operating Margin of 15.7% means the company generated kr0.16  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RaySearch Laboratories AB (publ):

  • The MRQ is 15.7%. The company is operating efficient. +1
  • The TTM is -6.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ15.7%TTM-6.0%+21.8%
TTM-6.0%YOY4.4%-10.5%
TTM-6.0%5Y0.5%-6.6%
5Y0.5%10Y6.9%-6.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ15.7%-22.7%+38.4%
TTM-6.0%-16.4%+10.4%
YOY4.4%-22.8%+27.2%
5Y0.5%-18.4%+18.9%
10Y6.9%-32.1%+39.0%
1.2.2. Operating Ratio

Measures how efficient RaySearch Laboratories AB (publ) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are kr0.84 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of RaySearch Laboratories AB (publ):

  • The MRQ is 0.843. The company is less efficient in keeping operating costs low.
  • The TTM is 0.888. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.843TTM0.888-0.045
TTM0.888YOY0.973-0.085
TTM0.8885Y0.979-0.091
5Y0.97910Y0.877+0.101
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8431.370-0.527
TTM0.8881.385-0.497
YOY0.9731.389-0.416
5Y0.9791.398-0.419
10Y0.8771.331-0.454

1.3. Liquidity of RaySearch Laboratories AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if RaySearch Laboratories AB (publ) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.22 means the company has kr1.22 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of RaySearch Laboratories AB (publ):

  • The MRQ is 1.220. The company is just able to pay all its short-term debts.
  • The TTM is 1.142. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.220TTM1.142+0.078
TTM1.142YOY1.066+0.076
TTM1.1425Y1.337-0.196
5Y1.33710Y2.228-0.890
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2201.811-0.591
TTM1.1421.813-0.671
YOY1.0662.055-0.989
5Y1.3372.589-1.252
10Y2.2282.589-0.361
1.3.2. Quick Ratio

Measures if RaySearch Laboratories AB (publ) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • A Quick Ratio of 1.21 means the company can pay off kr1.21 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RaySearch Laboratories AB (publ):

  • The MRQ is 1.206. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.110. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.206TTM1.110+0.096
TTM1.110YOY0.982+0.128
TTM1.1105Y1.285-0.175
5Y1.28510Y1.396-0.111
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2061.059+0.147
TTM1.1101.223-0.113
YOY0.9821.813-0.831
5Y1.2851.998-0.713
10Y1.3962.076-0.680

1.4. Solvency of RaySearch Laboratories AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of RaySearch Laboratories AB (publ) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare RaySearch Laboratories AB (publ) to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.62 means that RaySearch Laboratories AB (publ) assets are financed with 62.3% credit (debt) and the remaining percentage (100% - 62.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RaySearch Laboratories AB (publ):

  • The MRQ is 0.623. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.631. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.623TTM0.631-0.008
TTM0.631YOY0.634-0.003
TTM0.6315Y0.529+0.101
5Y0.52910Y0.441+0.088
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6230.380+0.243
TTM0.6310.383+0.248
YOY0.6340.399+0.235
5Y0.5290.411+0.118
10Y0.4410.450-0.009
1.4.2. Debt to Equity Ratio

Measures if RaySearch Laboratories AB (publ) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • A Debt to Equity ratio of 165.4% means that company has kr1.65 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RaySearch Laboratories AB (publ):

  • The MRQ is 1.654. The company is just able to pay all its debts with equity.
  • The TTM is 1.710. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.654TTM1.710-0.056
TTM1.710YOY1.737-0.026
TTM1.7105Y1.217+0.493
5Y1.21710Y0.882+0.334
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6540.595+1.059
TTM1.7100.577+1.133
YOY1.7370.607+1.130
5Y1.2170.709+0.508
10Y0.8820.616+0.266

2. Market Valuation of RaySearch Laboratories AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings RaySearch Laboratories AB (publ) generates.

  • Above 15 is considered overpriced but always compare RaySearch Laboratories AB (publ) to the Health Information Services industry mean.
  • A PE ratio of 24.53 means the investor is paying kr24.53 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RaySearch Laboratories AB (publ):

  • The EOD is 32.274. Based on the earnings, the company is overpriced. -1
  • The MRQ is 24.532. Based on the earnings, the company is fair priced.
  • The TTM is 36.204. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD32.274MRQ24.532+7.743
MRQ24.532TTM36.204-11.672
TTM36.204YOY20.264+15.940
TTM36.2045Y0.693+35.511
5Y0.69310Y8,455.202-8,454.509
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD32.274-1.570+33.844
MRQ24.532-2.188+26.720
TTM36.204-2.131+38.335
YOY20.264-3.673+23.937
5Y0.693-5.005+5.698
10Y8,455.202-4.981+8,460.183
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RaySearch Laboratories AB (publ):

  • The EOD is 19.881. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.112. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.710. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.881MRQ15.112+4.769
MRQ15.112TTM19.710-4.599
TTM19.710YOY15.654+4.057
TTM19.7105Y13.840+5.871
5Y13.84010Y23.214-9.374
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD19.881-1.438+21.319
MRQ15.112-1.799+16.911
TTM19.710-2.834+22.544
YOY15.654-5.673+21.327
5Y13.840-4.197+18.037
10Y23.214-3.814+27.028
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of RaySearch Laboratories AB (publ) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 4.20 means the investor is paying kr4.20 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of RaySearch Laboratories AB (publ):

  • The EOD is 5.530. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.203. Based on the equity, the company is fair priced.
  • The TTM is 3.821. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.530MRQ4.203+1.327
MRQ4.203TTM3.821+0.382
TTM3.821YOY2.920+0.901
TTM3.8215Y4.294-0.472
5Y4.29410Y7.776-3.483
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD5.5301.776+3.754
MRQ4.2031.873+2.330
TTM3.8211.943+1.878
YOY2.9202.978-0.058
5Y4.2943.998+0.296
10Y7.7764.198+3.578
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of RaySearch Laboratories AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8010.578+39%2.776-71%0.115+595%0.394+103%
Book Value Per Share--21.48320.477+5%18.981+13%19.537+10%15.536+38%
Current Ratio--1.2201.142+7%1.066+14%1.337-9%2.228-45%
Debt To Asset Ratio--0.6230.631-1%0.634-2%0.529+18%0.441+41%
Debt To Equity Ratio--1.6541.710-3%1.737-5%1.217+36%0.882+87%
Dividend Per Share----0%-0%-0%-0%
Eps--0.9200.595+55%0.173+431%0.158+481%0.421+119%
Free Cash Flow Per Share--1.4942.114-29%2.284-35%1.517-2%0.718+108%
Free Cash Flow To Equity Per Share--1.3291.728-23%1.712-22%0.983+35%0.524+154%
Gross Profit Margin--1.000-3.245+424%-2.560+356%0.235+326%-463.457+46446%
Intrinsic Value_10Y_max--438.083--------
Intrinsic Value_10Y_min--58.451--------
Intrinsic Value_1Y_max--13.245--------
Intrinsic Value_1Y_min--3.400--------
Intrinsic Value_3Y_max--63.157--------
Intrinsic Value_3Y_min--12.405--------
Intrinsic Value_5Y_max--141.236--------
Intrinsic Value_5Y_min--23.739--------
Market Cap3163382640.000+2%3094937685.0002687570223.975+15%1900123731.000+63%2954949077.075+5%3699420380.325-16%
Net Profit Margin--0.1050.078+35%0.018+495%0.007+1335%0.093+14%
Operating Margin--0.157-0.060+138%0.044+254%0.005+2950%0.069+129%
Operating Ratio--0.8430.888-5%0.973-13%0.979-14%0.877-4%
Pb Ratio5.530+24%4.2033.821+10%2.920+44%4.294-2%7.776-46%
Pe Ratio32.274+24%24.53236.204-32%20.264+21%0.693+3439%8455.202-100%
Price Per Share118.800+24%90.30078.400+15%55.425+63%82.440+10%103.005-12%
Price To Free Cash Flow Ratio19.881+24%15.11219.710-23%15.654-3%13.840+9%23.214-35%
Price To Total Gains Ratio148.260+24%112.693140.024-20%67.035+68%8.246+1267%-57.821+151%
Quick Ratio--1.2061.110+9%0.982+23%1.285-6%1.396-14%
Return On Assets--0.0160.011+51%0.003+375%0.003+536%0.021-22%
Return On Equity--0.0430.029+49%0.009+394%0.007+533%0.033+28%
Total Gains Per Share--0.8010.578+39%2.776-71%0.115+595%0.394+103%
Usd Book Value--67665326.70064509618.550+5%59802087.000+13%63225311.455+7%50294071.645+35%
Usd Book Value Change Per Share--0.0740.053+39%0.255-71%0.011+595%0.036+103%
Usd Book Value Per Share--1.9741.882+5%1.744+13%1.795+10%1.428+38%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0850.055+55%0.016+431%0.015+481%0.039+119%
Usd Free Cash Flow--4705371.9006661348.525-29%7197194.450-35%4849457.315-3%2349814.075+100%
Usd Free Cash Flow Per Share--0.1370.194-29%0.210-35%0.139-2%0.066+108%
Usd Free Cash Flow To Equity Per Share--0.1220.159-23%0.157-22%0.090+35%0.048+154%
Usd Market Cap290714864.616+2%284424773.252246987703.583+15%174621370.879+63%271559820.183+5%339976732.952-16%
Usd Price Per Share10.918+24%8.2997.205+15%5.094+63%7.576+10%9.466-12%
Usd Profit--2898526.0001874116.700+55%546299.550+431%456586.770+535%1325577.088+119%
Usd Revenue--27536916.00023484103.025+17%19382812.800+42%17923606.220+54%14536893.635+89%
Usd Total Gains Per Share--0.0740.053+39%0.255-71%0.011+595%0.036+103%
 EOD+4 -4MRQTTM+26 -8YOY+22 -125Y+24 -1010Y+26 -8

3.2. Fundamental Score

Let's check the fundamental score of RaySearch Laboratories AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.274
Price to Book Ratio (EOD)Between0-15.530
Net Profit Margin (MRQ)Greater than00.105
Operating Margin (MRQ)Greater than00.157
Quick Ratio (MRQ)Greater than11.206
Current Ratio (MRQ)Greater than11.220
Debt to Asset Ratio (MRQ)Less than10.623
Debt to Equity Ratio (MRQ)Less than11.654
Return on Equity (MRQ)Greater than0.150.043
Return on Assets (MRQ)Greater than0.050.016
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of RaySearch Laboratories AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.939
Ma 20Greater thanMa 50117.020
Ma 50Greater thanMa 100107.074
Ma 100Greater thanMa 20099.132
OpenGreater thanClose117.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets1,952,666
Total Liabilities1,216,373
Total Stockholder Equity735,232
 As reported
Total Liabilities 1,216,373
Total Stockholder Equity+ 735,232
Total Assets = 1,952,666

Assets

Total Assets1,952,666
Total Current Assets823,386
Long-term Assets1,129,280
Total Current Assets
Cash And Cash Equivalents 343,681
Net Receivables 470,385
Inventory 9,320
Total Current Assets  (as reported)823,386
Total Current Assets  (calculated)823,386
+/-0
Long-term Assets
Property Plant Equipment 590,416
Long-term Assets Other 530,455
Long-term Assets  (as reported)1,129,280
Long-term Assets  (calculated)1,120,871
+/- 8,409

Liabilities & Shareholders' Equity

Total Current Liabilities675,049
Long-term Liabilities541,324
Total Stockholder Equity735,232
Total Current Liabilities
Short-term Debt 97,381
Accounts payable 42,085
Other Current Liabilities 535,583
Total Current Liabilities  (as reported)675,049
Total Current Liabilities  (calculated)675,049
+/- 0
Long-term Liabilities
Long-term Liabilities  (as reported)541,324
Long-term Liabilities  (calculated)0
+/- 541,324
Total Stockholder Equity
Common Stock17,141
Other Stockholders Equity 718,091
Total Stockholder Equity (as reported)735,232
Total Stockholder Equity (calculated)735,232
+/-0
Other
Cash and Short Term Investments 343,681
Common Stock Shares Outstanding 34,274
Current Deferred Revenue0
Liabilities and Stockholders Equity 1,952,666
Net Debt 185,677
Net Working Capital 148,337
Short Long Term Debt Total 529,358



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
233,098
240,978
242,830
239,169
255,926
257,446
241,386
249,218
260,998
264,709
260,372
260,721
293,027
297,510
281,504
267,761
299,162
296,996
294,498
304,252
389,753
437,952
429,994
459,519
484,490
508,283
555,072
586,110
717,254
735,896
757,367
756,269
915,064
933,450
995,971
1,043,015
1,105,422
1,292,615
1,242,160
1,235,794
1,264,224
1,339,106
1,309,555
1,244,463
1,284,904
1,333,511
1,187,153
1,172,051
1,739,038
1,722,490
1,796,815
1,724,030
1,875,950
1,885,313
1,897,769
1,866,604
1,952,666
1,952,6661,866,6041,897,7691,885,3131,875,9501,724,0301,796,8151,722,4901,739,0381,172,0511,187,1531,333,5111,284,9041,244,4631,309,5551,339,1061,264,2241,235,7941,242,1601,292,6151,105,4221,043,015995,971933,450915,064756,269757,367735,896717,254586,110555,072508,283484,490459,519429,994437,952389,753304,252294,498296,996299,162267,761281,504297,510293,027260,721260,372264,709260,998249,218241,386257,446255,926239,169242,830240,978233,098000
   > Total Current Assets 
0
0
0
110,491
114,263
109,631
102,256
114,946
110,245
85,569
87,631
95,924
97,179
89,529
90,868
123,390
125,595
107,152
95,964
126,514
123,736
121,583
134,485
212,721
238,422
210,711
235,896
247,559
261,669
299,690
319,433
435,589
425,859
429,881
419,993
543,888
549,398
573,366
600,222
604,138
621,598
551,866
567,413
581,802
620,435
593,900
534,128
577,164
619,549
470,032
459,470
516,369
516,492
575,588
535,410
627,922
654,870
684,499
724,456
823,386
823,386724,456684,499654,870627,922535,410575,588516,492516,369459,470470,032619,549577,164534,128593,900620,435581,802567,413551,866621,598604,138600,222573,366549,398543,888419,993429,881425,859435,589319,433299,690261,669247,559235,896210,711238,422212,721134,485121,583123,736126,51495,964107,152125,595123,39090,86889,52997,17995,92487,63185,569110,245114,946102,256109,631114,263110,491000
       Cash And Cash Equivalents 
0
0
0
80,013
78,176
82,092
77,226
75,016
71,664
47,904
44,016
28,704
39,572
49,771
43,238
61,875
62,291
42,615
33,855
38,231
34,749
27,010
24,778
56,085
64,540
53,906
47,577
59,705
54,644
33,526
29,837
87,720
84,432
70,165
69,591
104,156
117,871
69,153
52,893
112,198
113,172
118,125
107,482
113,858
112,660
173,728
194,140
168,746
205,215
128,815
120,589
102,535
139,816
162,068
118,194
160,268
243,719
246,228
306,632
343,681
343,681306,632246,228243,719160,268118,194162,068139,816102,535120,589128,815205,215168,746194,140173,728112,660113,858107,482118,125113,172112,19852,89369,153117,871104,15669,59170,16584,43287,72029,83733,52654,64459,70547,57753,90664,54056,08524,77827,01034,74938,23133,85542,61562,29161,87543,23849,77139,57228,70444,01647,90471,66475,01677,22682,09278,17680,013000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
341,562
248,020
343,094
335,054
419,025
430,606
503,688
547,103
459,357
505,495
429,890
445,616
422,722
499,947
411,969
326,228
361,607
392,145
320,900
317,586
397,440
338,224
369,586
387,773
398,264
388,225
411,630
398,001
470,385
470,385398,001411,630388,225398,264387,773369,586338,224397,440317,586320,900392,145361,607326,228411,969499,947422,722445,616429,890505,495459,357547,103503,688430,606419,025335,054343,094248,020341,5620000000000000000000000000000000
       Other Current Assets 
0
0
0
30,478
36,087
27,539
25,030
39,930
38,581
37,665
43,615
67,220
57,607
39,758
47,630
61,515
63,304
64,537
62,109
88,283
88,987
94,573
109,707
156,636
173,882
156,805
188,319
187,854
207,025
266,164
289,596
347,869
341,427
359,716
349,680
439,699
430,606
503,688
547,103
482,323
505,495
429,890
445,616
463,321
499,947
411,969
326,228
399,308
392,145
320,900
317,586
383,843
338,224
369,586
387,773
55,299
0
80,291
0
0
0080,291055,299387,773369,586338,224383,843317,586320,900392,145399,308326,228411,969499,947463,321445,616429,890505,495482,323547,103503,688430,606439,699349,680359,716341,427347,869289,596266,164207,025187,854188,319156,805173,882156,636109,70794,57388,98788,28362,10964,53763,30461,51547,63039,75857,60767,22043,61537,66538,58139,93025,03027,53936,08730,478000
   > Long-term Assets 
0
0
0
122,607
126,715
133,199
136,913
140,980
147,201
155,817
161,587
165,074
167,530
170,843
169,853
169,637
171,915
174,352
171,797
172,648
173,260
172,915
169,767
177,032
199,530
219,283
223,623
236,931
246,614
255,382
266,677
281,665
310,037
327,486
336,276
371,176
384,052
422,605
442,793
501,284
671,017
690,294
668,381
682,422
718,671
715,655
710,335
707,740
713,962
717,121
712,581
1,222,669
1,205,998
1,221,227
1,188,620
1,248,028
1,230,443
1,213,270
1,142,148
1,129,280
1,129,2801,142,1481,213,2701,230,4431,248,0281,188,6201,221,2271,205,9981,222,669712,581717,121713,962707,740710,335715,655718,671682,422668,381690,294671,017501,284442,793422,605384,052371,176336,276327,486310,037281,665266,677255,382246,614236,931223,623219,283199,530177,032169,767172,915173,260172,648171,797174,352171,915169,637169,853170,843167,530165,074161,587155,817147,201140,980136,913133,199126,715122,607000
       Property Plant Equipment 
0
0
0
2,068
2,314
3,184
3,177
3,157
2,895
4,097
4,044
3,978
4,076
4,482
4,132
3,711
3,852
3,867
4,985
5,567
6,303
7,060
7,367
12,951
31,744
45,482
45,072
41,760
40,317
38,198
37,407
35,667
35,336
38,178
38,417
36,114
37,892
59,177
65,833
93,081
254,622
254,186
232,744
221,349
242,491
224,729
207,540
186,768
183,327
181,639
175,217
666,539
650,769
652,844
634,095
649,070
625,359
608,169
589,206
590,416
590,416589,206608,169625,359649,070634,095652,844650,769666,539175,217181,639183,327186,768207,540224,729242,491221,349232,744254,186254,62293,08165,83359,17737,89236,11438,41738,17835,33635,66737,40738,19840,31741,76045,07245,48231,74412,9517,3677,0606,3035,5674,9853,8673,8523,7114,1324,4824,0763,9784,0444,0972,8953,1573,1773,1842,3142,068000
       Intangible Assets 
0
0
0
112,323
116,185
121,799
125,520
133,981
140,464
147,878
153,701
161,096
0
0
0
165,926
0
0
0
166,678
0
0
0
164,081
0
0
0
195,114
0
0
0
243,219
258,305
274,234
290,201
322,598
338,211
355,453
361,875
377,341
388,683
401,549
408,422
428,406
449,029
466,240
470,590
486,817
499,031
511,323
508,025
523,109
530,427
531,020
520,258
518,663
526,772
532,123
0
0
00532,123526,772518,663520,258531,020530,427523,109508,025511,323499,031486,817470,590466,240449,029428,406408,422401,549388,683377,341361,875355,453338,211322,598290,201274,234258,305243,219000195,114000164,081000166,678000165,926000161,096153,701147,878140,464133,981125,520121,799116,185112,323000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,779
16,396
15,074
7,658
12,464
7,949
7,975
15,085
30,862
27,712
34,559
27,215
32,666
27,151
24,686
32,205
34,155
31,604
24,159
29,339
30,681
24,802
37,363
27,438
25,598
25,141
21,461
31,812
0
031,81221,46125,14125,59827,43837,36324,80230,68129,33924,15931,60434,15532,20524,68627,15132,66627,21534,55927,71230,86215,0857,9757,94912,4647,65815,07416,3962,7790000000000000000000000000000000
> Total Liabilities 
0
0
0
48,240
47,886
57,609
53,761
59,164
59,181
60,442
59,457
64,301
63,138
67,710
68,767
75,474
74,809
75,674
75,665
102,561
94,490
93,046
91,025
138,205
164,215
157,583
173,074
164,973
170,519
198,434
200,174
257,066
249,056
249,117
248,142
334,639
341,119
384,533
418,055
447,969
620,036
547,766
548,939
558,756
592,117
573,140
534,598
590,553
630,920
501,481
507,657
1,089,760
1,053,277
1,165,228
1,079,066
1,218,794
1,210,929
1,209,640
1,157,592
1,216,373
1,216,3731,157,5921,209,6401,210,9291,218,7941,079,0661,165,2281,053,2771,089,760507,657501,481630,920590,553534,598573,140592,117558,756548,939547,766620,036447,969418,055384,533341,119334,639248,142249,117249,056257,066200,174198,434170,519164,973173,074157,583164,215138,20591,02593,04694,490102,56175,66575,67474,80975,47468,76767,71063,13864,30159,45760,44259,18159,16453,76157,60947,88648,240000
   > Total Current Liabilities 
0
0
0
12,649
11,242
19,451
14,639
16,755
15,047
16,650
13,985
17,287
15,498
19,300
20,521
34,508
33,370
33,698
34,495
43,942
23,089
33,508
30,373
56,385
74,596
61,634
76,773
75,460
79,571
106,113
95,518
124,938
123,573
161,202
156,609
232,464
236,223
276,216
311,897
336,800
373,463
315,400
339,896
357,815
384,761
373,061
345,012
428,016
466,300
337,010
345,428
490,080
457,622
560,461
493,338
614,098
619,777
632,137
600,045
675,049
675,049600,045632,137619,777614,098493,338560,461457,622490,080345,428337,010466,300428,016345,012373,061384,761357,815339,896315,400373,463336,800311,897276,216236,223232,464156,609161,202123,573124,93895,518106,11379,57175,46076,77361,63474,59656,38530,37333,50823,08943,94234,49533,69833,37034,50820,52119,30015,49817,28713,98516,65015,04716,75514,63919,45111,24212,649000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,667
0
0
0
0
0
0
0
0
0
0
0
61,527
51,563
49,324
128,182
74,033
74,133
74,083
114,055
124,283
124,383
49,333
86,386
84,931
97,840
96,654
96,651
92,519
84,828
26,731
17,226
70,381
50,500
52,678
53,940
58,307
57,255
58,581
56,924
97,381
97,38156,92458,58157,25558,30753,94052,67850,50070,38117,22626,73184,82892,51996,65196,65497,84084,93186,38649,333124,383124,283114,05574,08374,13374,033128,18249,32451,56361,527000000000001,6670000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,527
51,563
49,324
38,933
71,138
74,133
74,083
114,055
120,563
124,383
49,333
86,386
84,931
97,840
96,654
0
0
0
0
0
21,268
0
0
0
0
0
0
0
0
0000000021,2680000096,65497,84084,93186,38649,333124,383120,563114,05574,08374,13371,13838,93349,32451,56361,5270000000000000000000000000000000
       Accounts payable 
0
0
0
5,525
1,655
4,065
3,521
5,743
3,913
4,939
4,428
6,582
3,131
5,248
4,986
11,717
10,712
5,139
6,956
6,925
6,289
7,326
5,023
9,034
21,278
7,904
17,732
9,514
17,861
20,467
12,497
11,943
13,156
17,274
28,427
27,403
22,700
17,698
21,537
32,366
30,016
33,090
24,871
33,202
21,463
15,575
11,128
19,864
21,975
32,049
30,076
48,774
29,852
43,549
25,629
24,030
30,278
27,978
51,379
42,085
42,08551,37927,97830,27824,03025,62943,54929,85248,77430,07632,04921,97519,86411,12815,57521,46333,20224,87133,09030,01632,36621,53717,69822,70027,40328,42717,27413,15611,94312,49720,46717,8619,51417,7327,90421,2789,0345,0237,3266,2896,9256,9565,13910,71211,7174,9865,2483,1316,5824,4284,9393,9135,7433,5214,0651,6555,525000
       Other Current Liabilities 
0
0
0
7,124
9,587
15,386
11,118
11,012
11,134
11,711
9,557
10,705
12,367
14,052
15,535
22,791
22,658
28,559
27,539
35,350
16,800
26,182
25,350
47,351
53,318
53,730
59,041
65,946
61,710
85,646
83,021
112,995
110,417
143,928
5,070
131,028
139,390
184,435
176,305
180,151
219,064
232,977
228,639
239,682
265,458
260,832
237,233
315,633
359,497
278,230
298,126
370,925
377,270
464,234
413,769
71,048
532,244
545,578
491,742
535,583
535,583491,742545,578532,24471,048413,769464,234377,270370,925298,126278,230359,497315,633237,233260,832265,458239,682228,639232,977219,064180,151176,305184,435139,390131,0285,070143,928110,417112,99583,02185,64661,71065,94659,04153,73053,31847,35125,35026,18216,80035,35027,53928,55922,65822,79115,53514,05212,36710,7059,55711,71111,13411,01211,11815,3869,5877,124000
   > Long-term Liabilities 
0
0
0
35,591
36,644
38,158
39,122
42,409
44,134
43,792
45,472
47,014
47,640
48,410
48,246
40,966
41,439
41,976
41,170
58,619
71,401
59,538
60,652
81,820
89,619
95,949
96,301
89,513
90,948
92,321
104,656
132,128
125,483
87,915
91,533
102,175
104,896
108,317
106,158
111,169
246,573
232,366
209,043
200,941
207,356
200,079
189,586
162,537
164,620
164,471
162,229
599,680
595,655
604,767
585,728
604,696
591,152
577,503
557,547
541,324
541,324557,547577,503591,152604,696585,728604,767595,655599,680162,229164,471164,620162,537189,586200,079207,356200,941209,043232,366246,573111,169106,158108,317104,896102,17591,53387,915125,483132,128104,65692,32190,94889,51396,30195,94989,61981,82060,65259,53871,40158,61941,17041,97641,43940,96648,24648,41047,64047,01445,47243,79244,13442,40939,12238,15836,64435,591000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,013
53,788
54,435
51,699
50,380
491,896
486,361
495,626
478,527
497,822
482,724
465,634
0
0
00465,634482,724497,822478,527495,626486,361491,89650,38051,69954,43553,78866,0130000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,601
73,920
77,424
80,937
92,424
95,859
99,652
98,215
103,954
106,093
108,566
109,956
115,145
119,305
122,799
123,573
108,749
110,185
112,772
111,849
107,784
109,294
109,141
107,201
106,874
0
109,571
107,318
0
0107,318109,5710106,874107,201109,141109,294107,784111,849112,772110,185108,749123,573122,799119,305115,145109,956108,566106,093103,95498,21599,65295,85992,42480,93777,42473,92070,6010000000000000000000000000000000
> Total Stockholder Equity
0
0
0
184,858
193,092
185,221
185,408
196,762
198,265
180,944
189,761
196,697
201,571
192,662
191,954
217,553
222,701
205,830
192,096
196,601
202,506
201,452
213,227
251,548
273,737
272,411
286,445
319,517
337,764
356,638
385,936
460,188
486,840
508,250
508,127
580,425
592,331
611,438
624,960
657,453
672,579
694,394
686,855
705,468
746,989
736,415
709,865
694,351
702,591
685,672
664,394
649,278
669,213
631,587
644,964
657,156
674,384
688,129
709,012
735,232
735,232709,012688,129674,384657,156644,964631,587669,213649,278664,394685,672702,591694,351709,865736,415746,989705,468686,855694,394672,579657,453624,960611,438592,331580,425508,127508,250486,840460,188385,936356,638337,764319,517286,445272,411273,737251,548213,227201,452202,506196,601192,096205,830222,701217,553191,954192,662201,571196,697189,761180,944198,265196,762185,408185,221193,092184,858000
   Common Stock
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
0
0
0
17,141
486,840
508,250
17,141
17,141
592,331
611,438
17,141
17,141
657,453
17,141
17,141
17,141
746,989
17,141
17,141
17,141
17,141
17,141
17,141
17,141
17,141
631,587
17,141
17,141
17,141
17,141
17,141
17,141
17,14117,14117,14117,14117,14117,141631,58717,14117,14117,14117,14117,14117,14117,14117,141746,98917,14117,14117,141657,45317,14117,141611,438592,33117,14117,141508,250486,84017,14100017,14100017,14100017,14100017,14100017,14100017,14100017,141000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000-2,3700000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,975
0
0
0
1,975
0
0
0
1,975
0
0
0
1,975
0
0
0
1,975
0
0
0
1,975
0
0
0
-4,181
0
0
0
-6,348
0
0
490,986
-3,738
0
0
607,819
-5,232
-2,040
677,253
669,714
-5,666
746,989
719,274
692,724
-7,703
685,450
668,531
664,394
-5,461
669,213
631,587
644,964
-395
657,243
670,988
691,871
718,091
718,091691,871670,988657,243-395644,964631,587669,213-5,461664,394668,531685,450-7,703692,724719,274746,989-5,666669,714677,253-2,040-5,232607,81900-3,738490,98600-6,348000-4,1810001,9750001,9750001,9750001,9750001,9750001,975000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,022,159
Cost of Revenue-391,782
Gross Profit630,377630,377
 
Operating Income (+$)
Gross Profit630,377
Operating Expense-510,541
Operating Income119,836119,836
 
Operating Expense (+$)
Research Development237,736
Selling General Administrative540,305
Selling And Marketing Expenses0
Operating Expense510,541778,041
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,792
Other Finance Cost-1,907
Net Interest Income-6,699
 
Pretax Income (+$)
Operating Income119,836
Net Interest Income-6,699
Other Non-Operating Income Expenses0
Income Before Tax (EBT)110,088129,584
EBIT - interestExpense = 115,044
110,088
86,364
Interest Expense4,792
Earnings Before Interest and Taxes (EBIT)119,836114,880
Earnings Before Interest and Taxes (EBITDA)405,040
 
After tax Income (+$)
Income Before Tax110,088
Tax Provision-20,349
Net Income From Continuing Ops64,17089,739
Net Income81,572
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses902,323
Total Other Income/Expenses Net-9,7486,699
 

Technical Analysis of RaySearch Laboratories AB (publ)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of RaySearch Laboratories AB (publ). The general trend of RaySearch Laboratories AB (publ) is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine RaySearch Laboratories AB (publ)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RaySearch Laboratories AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 123.80.

The bearish price targets are: 110.00 > 99.80 > 98.00.

Tweet this
RaySearch Laboratories AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RaySearch Laboratories AB (publ). The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RaySearch Laboratories AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RaySearch Laboratories AB (publ). The current macd is 2.61353288.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the RaySearch Laboratories AB (publ) price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for RaySearch Laboratories AB (publ). This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the RaySearch Laboratories AB (publ) price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
RaySearch Laboratories AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartRaySearch Laboratories AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RaySearch Laboratories AB (publ). The current adx is 29.46.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy RaySearch Laboratories AB (publ) shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
RaySearch Laboratories AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RaySearch Laboratories AB (publ). The current sar is 120.55.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
RaySearch Laboratories AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RaySearch Laboratories AB (publ). The current rsi is 60.94. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
RaySearch Laboratories AB (publ) Daily Relative Strength Index (RSI) ChartRaySearch Laboratories AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RaySearch Laboratories AB (publ). The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the RaySearch Laboratories AB (publ) price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
RaySearch Laboratories AB (publ) Daily Stochastic Oscillator ChartRaySearch Laboratories AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RaySearch Laboratories AB (publ). The current cci is 27.36.

RaySearch Laboratories AB (publ) Daily Commodity Channel Index (CCI) ChartRaySearch Laboratories AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RaySearch Laboratories AB (publ). The current cmo is 19.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
RaySearch Laboratories AB (publ) Daily Chande Momentum Oscillator (CMO) ChartRaySearch Laboratories AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RaySearch Laboratories AB (publ). The current willr is -38.46153846.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that RaySearch Laboratories AB (publ) is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
RaySearch Laboratories AB (publ) Daily Williams %R ChartRaySearch Laboratories AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RaySearch Laboratories AB (publ).

RaySearch Laboratories AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RaySearch Laboratories AB (publ). The current atr is 3.70002137.

RaySearch Laboratories AB (publ) Daily Average True Range (ATR) ChartRaySearch Laboratories AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RaySearch Laboratories AB (publ). The current obv is 6,941,799.

RaySearch Laboratories AB (publ) Daily On-Balance Volume (OBV) ChartRaySearch Laboratories AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RaySearch Laboratories AB (publ). The current mfi is 66.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
RaySearch Laboratories AB (publ) Daily Money Flow Index (MFI) ChartRaySearch Laboratories AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RaySearch Laboratories AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

RaySearch Laboratories AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RaySearch Laboratories AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.939
Ma 20Greater thanMa 50117.020
Ma 50Greater thanMa 100107.074
Ma 100Greater thanMa 20099.132
OpenGreater thanClose117.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of RaySearch Laboratories AB (publ) with someone you think should read this too:
  • Are you bullish or bearish on RaySearch Laboratories AB (publ)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about RaySearch Laboratories AB (publ)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RaySearch Laboratories AB (publ)

I send you an email if I find something interesting about RaySearch Laboratories AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about RaySearch Laboratories AB (publ).

Receive notifications about RaySearch Laboratories AB (publ) in your mailbox!